InterCure (NASDAQ:INCR) Trading Up 0.7% – What’s Next?

InterCure Ltd. (NASDAQ:INCR)’s stock price was up 0.7% on Friday . The company traded as high as $1.3110 and last traded at $1.3110. Approximately 2,047 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 22,058 shares. The stock had previously closed at $1.3023.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of InterCure in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has an average rating of “Sell”.

InterCure Price Performance

The company’s 50-day moving average is $1.48 and its 200-day moving average is $1.53. The firm has a market capitalization of $59.74 million, a price-to-earnings ratio of 10.08 and a beta of 1.18. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.85 and a quick ratio of 1.09.

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.